한글목차

인젝션 펜 시장은 2023-20281년간 255억 1,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 8.13%를 나타낼 것으로 예측됩니다.

인젝션 펜 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 만성질환 유병률 상승, 당뇨병 환자 증가, 주사 요법의 인기가 시장 성장을 가속하고 있습니다.

향후 몇 년간 인젝션 펜 시장 성장을 가속하는 주요인 중 하나로서 인슐린 펜의 대폭적인 수요 증가를 들고 있습니다. 벤더에 의한 인젝션 펜 제품 출시 증가, 신제품의 상업 인가 증가가 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 인젝션 펜 시장(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 성장호르몬 : 시장 규모와 예측(2023-2028년)
• 당뇨병 : 시장 규모와 예측(2023-2028년)
• 수태능력 : 시장 규모와 예측(2023-2028년)
• 골다공증 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제7장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 일회용 인젝션 펜 : 시장 규모와 예측(2023-2028년)
• 재이용 인젝션 펜 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• AstraZeneca Plc
• Becton Dickinson and Co.
• Biocon Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Gerresheimer AG
• GlaxoSmithKline Plc
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• Owen Mumford Ltd.
• Pfizer Inc.
• Sanofi
• Viatris Inc.
• Ypsomed Holding AG

제13장 부록

영문목차

The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.

Technavio's injection pen market is segmented as below:

By Product

• Growth hormone
• Diabetes
• Fertility
• Osteoporosis
• Others

By Type

• Disposable injection pen
• Reusable injection pen

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market vendors and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:

• Injection pen market sizing
• Injection pen market forecast
• Injection pen market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global injection pen market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Growth hormone - Market size and forecast 2023-2028
• Exhibit 34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
• 6.4 Diabetes - Market size and forecast 2023-2028
• Exhibit 38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
• 6.5 Fertility - Market size and forecast 2023-2028
• Exhibit 42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
• 6.6 Osteoporosis - Market size and forecast 2023-2028
• Exhibit 46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 56: Chart on Type - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 58: Chart on Comparison by Type
• Exhibit 59: Data Table on Comparison by Type
• 7.3 Disposable injection pen - Market size and forecast 2023-2028
• Exhibit 60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• 7.4 Reusable injection pen - Market size and forecast 2023-2028
• Exhibit 64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 68: Market opportunity by Type ($ billion)
• Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
• Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 AstraZeneca Plc
• Exhibit 119: AstraZeneca Plc - Overview
• Exhibit 120: AstraZeneca Plc - Product / Service
• Exhibit 121: AstraZeneca Plc - Key news
• Exhibit 122: AstraZeneca Plc - Key offerings
• 12.4 Becton Dickinson and Co.
• Exhibit 123: Becton Dickinson and Co. - Overview
• Exhibit 124: Becton Dickinson and Co. - Business segments
• Exhibit 125: Becton Dickinson and Co. - Key news
• Exhibit 126: Becton Dickinson and Co. - Key offerings
• Exhibit 127: Becton Dickinson and Co. - Segment focus
• 12.5 Biocon Ltd.
• Exhibit 128: Biocon Ltd. - Overview
• Exhibit 129: Biocon Ltd. - Business segments
• Exhibit 130: Biocon Ltd. - Key offerings
• Exhibit 131: Biocon Ltd. - Segment focus
• 12.6 Eli Lilly and Co.
• Exhibit 132: Eli Lilly and Co. - Overview
• Exhibit 133: Eli Lilly and Co. - Product / Service
• Exhibit 134: Eli Lilly and Co. - Key news
• Exhibit 135: Eli Lilly and Co. - Key offerings
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Gerresheimer AG
• Exhibit 141: Gerresheimer AG - Overview
• Exhibit 142: Gerresheimer AG - Business segments
• Exhibit 143: Gerresheimer AG - Key news
• Exhibit 144: Gerresheimer AG - Key offerings
• Exhibit 145: Gerresheimer AG - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 146: GlaxoSmithKline Plc - Overview
• Exhibit 147: GlaxoSmithKline Plc - Business segments
• Exhibit 148: GlaxoSmithKline Plc - Key news
• Exhibit 149: GlaxoSmithKline Plc - Key offerings
• Exhibit 150: GlaxoSmithKline Plc - Segment focus
• 12.10 Merck KGaA
• Exhibit 151: Merck KGaA - Overview
• Exhibit 152: Merck KGaA - Business segments
• Exhibit 153: Merck KGaA - Key news
• Exhibit 154: Merck KGaA - Key offerings
• Exhibit 155: Merck KGaA - Segment focus
• 12.11 Novartis AG
• Exhibit 156: Novartis AG - Overview
• Exhibit 157: Novartis AG - Business segments
• Exhibit 158: Novartis AG - Key offerings
• Exhibit 159: Novartis AG - Segment focus
• 12.12 Novo Nordisk AS
• Exhibit 160: Novo Nordisk AS - Overview
• Exhibit 161: Novo Nordisk AS - Business segments
• Exhibit 162: Novo Nordisk AS - Key offerings
• Exhibit 163: Novo Nordisk AS - Segment focus
• 12.13 Owen Mumford Ltd.
• Exhibit 164: Owen Mumford Ltd. - Overview
• Exhibit 165: Owen Mumford Ltd. - Product / Service
• Exhibit 166: Owen Mumford Ltd. - Key offerings
• 12.14 Pfizer Inc.
• Exhibit 167: Pfizer Inc. - Overview
• Exhibit 168: Pfizer Inc. - Product / Service
• Exhibit 169: Pfizer Inc. - Key news
• Exhibit 170: Pfizer Inc. - Key offerings
• 12.15 Sanofi
• Exhibit 171: Sanofi - Overview
• Exhibit 172: Sanofi - Business segments
• Exhibit 173: Sanofi - Key news
• Exhibit 174: Sanofi - Key offerings
• Exhibit 175: Sanofi - Segment focus
• 12.16 Viatris Inc.
• Exhibit 176: Viatris Inc. - Overview
• Exhibit 177: Viatris Inc. - Business segments
• Exhibit 178: Viatris Inc. - Key news
• Exhibit 179: Viatris Inc. - Key offerings
• Exhibit 180: Viatris Inc. - Segment focus
• 12.17 Ypsomed Holding AG
• Exhibit 181: Ypsomed Holding AG - Overview
• Exhibit 182: Ypsomed Holding AG - Business segments
• Exhibit 183: Ypsomed Holding AG - Key offerings
• Exhibit 184: Ypsomed Holding AG - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 185: Inclusions checklist
• Exhibit 186: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 187: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 188: Research methodology
• Exhibit 189: Validation techniques employed for market sizing
• Exhibit 190: Information sources
• 13.5 List of abbreviations
• Exhibit 191: List of abbreviations